6601 - 6625 of 8808 Results
Title
Year
-
OPENTitle: LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficitsJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 12Issue #: 540Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aav0820Citation Count: 114
-
OPENTitle: High‐molecular‐weight oligomer tau ( HMWoTau ) species are dramatically increased in Braak‐stage dependent manner in the frontal lobe of human brains, demonstrated by a novel oligomer Tau ELISA with a mouse monoclonal antibody ( APNmAb005 )Journal Name: The FASEB JournalPublisher: WileyVol: 38Issue #: 22Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1096/fj.202401704rBest OA location URL: https://doi.org/10.1096/fj.202401704rCitation Count: 3
-
OPENTitle: Conversion of Quinazoline Modulators from Inhibitors to Activators of β-GlucocerebrosidaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 62Issue #: 3Start Page: 1218End Page: 1230Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.8b01294Best OA location URL: https://doi.org/10.7270/q280562cCitation Count: 23
-
RESTRICTEDTitle: No Association Between Rare TWNK Variants and Parkinson's Disease in European CohortsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2318End Page: 2319Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29216Citation Count: 4
-
OPENTitle: Binding of the Human 14-3-3 Isoforms to Distinct Sites in the Leucine-Rich Repeat Kinase 2Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00302Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00302/pdfCitation Count: 56
-
RESTRICTEDTitle: Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmosetJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 873Issue #:Start Page: 172957End Page: 172957Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2020.172957Citation Count: 29
-
RESTRICTEDTitle: Altered reward-related neural responses in non-manifesting carriers of the Parkinson disease related LRRK2 mutationJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 13Issue #: 4Start Page: 1009End Page: 1020Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11682-018-9920-2Citation Count: 16
-
RESTRICTEDTitle: Objective characterization of daily living transitions in patients with Parkinson’s disease using a single body-fixed sensorJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 263Issue #: 8Start Page: 1544End Page: 1551Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-016-8164-6Citation Count: 46
-
OPENTitle: Regulation of Memory Formation by the Transcription Factor XBP1Journal Name: Cell ReportsPublisher: Elsevier BVVol: 14Issue #: 6Start Page: 1382End Page: 1394Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2016.01.028Best OA location URL: http://www.cell.com/article/S2211124716000498/pdfCitation Count: 157
- Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease2018OPENTitle: Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 26Issue #: 2Start Page: 246End Page: 246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.13797Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6329649Citation Count: 52
-
RESTRICTEDTitle: Activity‐dependent secretion of alpha‐synuclein by enteric neuronsJournal Name: Journal of NeurochemistryPublisher: WileyVol: 125Issue #: 4Start Page: 512End Page: 517Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.12131Citation Count: 96
- Effects of Tyrosine on Parkinson's Disease: A Randomized, Double‐Blind, Placebo‐Controlled Trial2014OPENTitle: Effects of Tyrosine on Parkinson's Disease: A Randomized, Double‐Blind, Placebo‐Controlled TrialJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 4Start Page: 348End Page: 353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12082Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12082Citation Count: 13
-
RESTRICTEDTitle: Attitudes toward use and timing of deep brain stimulation: a patient’s with DBS perspectiveJournal Name: Clinical Neurology and NeurosurgeryPublisher: Elsevier BVVol: 203Issue #:Start Page: 106553End Page: 106553Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clineuro.2021.106553Citation Count: 6
-
OPENTitle: Temporal discrimination threshold and blink reflex recovery cycle in cervical dystonia – two sides of the same coin?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 68Issue #:Start Page: 4End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.09.028Best OA location URL: https://eprints.soton.ac.uk/434837/1/PARKRELDIS_D_19_00249_unmarked.pdfCitation Count: 5
-
OPENTitle: Striatal and Cortical β‐Amyloidopathy and Cognition in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 1Start Page: 111End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26369Best OA location URL: http://doi.org/10.1002/mds.26369Citation Count: 61
-
OPENTitle: Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implicationsJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 96Issue #: 10Start Page: jnnpEnd Page: 335364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2024-335364Best OA location URL: https://doi.org/10.1136/jnnp-2024-335364Citation Count: 5
-
OPENTitle: Associations between daily-living physical activity and laboratory-based assessments of motor severity in patients with falls and Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 85End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.022Best OA location URL: http://www.prd-journal.com/article/S1353802019300227/pdfCitation Count: 81
-
RESTRICTEDTitle: The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurementsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 105Issue #:Start Page: 651End Page: 660Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.01.013Citation Count: 34
-
RESTRICTEDTitle: PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathologyJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 12Start Page: 1961End Page: 1965Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27523Citation Count: 45
-
OPENTitle: Synapsin III Regulates Dopaminergic Neuron Development in VertebratesJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 23Start Page: 3902End Page: 3902Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11233902Best OA location URL: https://www.mdpi.com/2073-4409/11/23/3902/pdf?version=1669977075Citation Count: 4
-
OPENTitle: Cryogel microcarriers loaded with glial cell line-derived neurotrophic factor enhance the engraftment of primary dopaminergic neurons in a rat model of Parkinson’s diseaseJournal Name: Journal of Neural EngineeringPublisher: IOP PublishingVol: 21Issue #: 5Start Page: 056011End Page: 056011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1088/1741-2552/ad7761Best OA location URL: http://doi.org/10.1088/1741-2552/ad7761Citation Count: 1
-
RESTRICTEDTitle: Validation of the MDS clinical diagnostic criteria for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1601End Page: 1608Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27362Citation Count: 241
-
OPENTitle: Semisynthetic and in Vitro Phosphorylation of Alpha-Synuclein at Y39 Promotes Functional Partly Helical Membrane-Bound States Resembling Those Induced by PD MutationsJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 11Issue #: 9Start Page: 2428End Page: 2437Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.6b00539Best OA location URL: https://infoscience.epfl.ch/handle/20.500.14299/131514Citation Count: 69
-
OPENTitle: Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 14Issue #: 6Start Page: e0217566End Page: e0217566Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0217566Citation Count: 49
-
OPENTitle: Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 19Issue #:Start Page: 1025End Page: 1035Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2018.05.006Best OA location URL: https://doi.org/10.1016/j.nicl.2018.05.006Citation Count: 55